Related Experiment Video
Updated: Jun 18, 2026
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
NAT10 promotes colon cancer progression by enhancing predicted N4-acetylcytidine modification of Notch2 mRNA
Wang Xiao-Jie1, Luo Ming2, Ni Ping3
1Department of General Surgery, LuoDian Hospital, Baoshan District, Shanghai, 201908, China.
Background:
Colon cancer is a prevalent malignant tumor with high mortality, and RNA modifications play critical roles in its progression. N-acetyltransferase 10 (NAT10)-mediated N4-acetylcytidine (ac4C) modification has emerged as a key epigenetic regulator in gastrointestinal cancers, but its role and mechanism in colon cancer remain unclear. This study investigated whether NAT10 regulates Notch2 via predicted ac4C modification to affect colon cancer progression.
Materials And Methods:
NAT10 and Notch2 expression was detected in 15 pairs of colon cancer and adjacent normal tissues. Colon cancer cell lines (HCT116, SW480) and normal colonic epithelial NCM460 cells were used. NAT10 overexpression/knockdown, NAT10 inhibitor Remodelin treatment, rescue experiments in both cell lines, and in vivo xenograft models were performed. CCK-8, Transwell, flow cytometry, TUNEL, acRIP-qPCR, RIP-qPCR, dual-luciferase reporter (WT/MUT), and mRNA stability assays were applied.
Results:
NAT10 and Notch2 were significantly upregulated in colon cancer tissues and cells, with a positive correlation trend (r = 0.3571, P = 0.1913). NAT10 knockdown inhibited proliferation, migration, and promoted apoptosis; overexpression exerted opposite effects. Remodelin inhibited NAT10 activity and downregulated Notch2 in a dose-dependent manner. Mechanistically, NAT10 bound to Notch2 mRNA, enhanced its predicted ac4C modification and stability. The predicted 3'UTR ac4C site was critical for NAT10-mediated regulation. Notch2 overexpression reversed NAT10 knockdown effects in both HCT116 and SW480 cells.In vivo subcutaneous xenograft models further confirmed that NAT10 knockdown significantly inhibits colon cancer tumor growth in mice, while Notch2 overexpression effectively rescues this inhibitory effect, supporting the oncogenic role of the NAT10/ac4C/Notch2 axis in vivo.
Conclusion:
NAT10 promotes colon cancer progression in an enzymatic activity‑dependent manner by enhancing predicted ac4C modification of Notch2 mRNA to stabilize its expression. This study reveals a novel NAT10/ac4C/Notch2 regulatory axis and provides potential therapeutic targets for colon cancer.
Related Concept Videos
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...